Cargando…
Pioglitazone Induces Dysplastic Urothelial Changes in Urinary Bladder of Experimental Diabetes
OBJECTIVES: Pioglitazone (PIO) is a widely prescribed oral antidiabetic drug that has concerns regarding a potential risk of developing carcinoma of the urinary bladder. The objective of the current study was to assess this potential risk. MATERIALS AND METHODS: The potential risk of PIO-induced uri...
Autores principales: | Abdel-Hamid, Ahmed A. M., Firgany, Alaa El-Din L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153741/ https://www.ncbi.nlm.nih.gov/pubmed/37144164 http://dx.doi.org/10.4103/jmau.jmau_34_21 |
Ejemplares similares
-
Thymoquinone Upregulates Catalase Gene Expression and Preserves the Structure of the Renal Cortex of Propylthiouracil-Induced Hypothyroid Rats
por: Ayuob, Nasra, et al.
Publicado: (2020) -
Urothelial Bladder Cancer Urinary Biomarkers
por: Noon, Aidan P, et al.
Publicado: (2014) -
Urothelial Papilloma of the Urinary Bladder: A Case Report and Literature Review of a Rare Entity
por: Abdel Gawad, Ahmed M, et al.
Publicado: (2022) -
Nested variant of urothelial carcinoma of the urinary bladder
por: Terada, Tadashi
Publicado: (2011) -
The Association of Pioglitazone and Urinary Tract Disease in Type 2 Diabetic Taiwanese: Bladder Cancer and Chronic Kidney Disease
por: Lee, Mei-Yueh, et al.
Publicado: (2014)